Amyloid-β oligomers stimulate microglia through a tyrosine kinase dependent mechanism
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) has been well characterized by the presence of reactive microglia, often associated with Aβ-plaque deposition. The oligomeric form of Aβ peptide (Aβo) has neurotoxic effects in the presence of microglia and is suggested to potentiate proinflammatory changes in microglia in AD. Primary murine microglia cultures stimulated with Aβo displayed increased protein phospho-tyrosine and secreted TNF-α levels which were attenuated by the Src/Abl inhibitor, dasatinib. Intracerebroventricular infusions of Aβo into C57BL6/J mice stimulated increased microgliosis and protein phospho-tyrosine levels that were also attenuated by dasatinib administration. The rodent findings were validated in human AD brains versus age-matched controls demonstrating reactive microglial association with Aβo deposits and increased microglial protein phospho-tyrosine and phospho-Src levels. These data suggest a role for Aβo in microglial activation through a tyrosine kinase-dependant pathway both in rodent models and human disease. Use of a selective non-receptor tyrosine kinase inhibitor such as dasatinib to attenuate microglial-dependent proinflammatory changes may prove to be an important step towards developing anti-inflammatory treatments for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedAlzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T. (2008) · Nature · doi:10.1038/nature06616 · Cited by 987
Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940
Research works printed but not linked: 32
- Akiyama, 1999, Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer's disease, Glia, 25, 324, 10.1002/(SICI)1098-1136(19990215)25:4<324::AID-GLIA2>3.0.CO;2-5 · doi:10.1002/(sici)1098-1136(19990215)25:4<324::aid-glia2>3.0.co;2-5
- Austin, 2009, Amyloid precursor protein mediates a tyrosine kinase-dependent activation response in endothelial cells, J. Neurosci, 29, 14451, 10.1523/JNEUROSCI.3107-09.2009 · DOI · Paper page
- Banati, 1993, Cytotoxicity of microglia, Glia, 7, 111, 10.1002/glia.440070117 · DOI · Paper page
- Benzing, 1999, Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice, Neurobiol. Aging, 20, 581, 10.1016/S0197-4580(99)00065-2 · DOI · Paper page
- Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 · DOI · Paper page
- Cleary, 2005, Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function, Nat. Neurosci, 8, 79, 10.1038/nn1372 · DOI · Paper page
- Combs, 2001, Regulation of beta-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor alpha, Neurochem. Int, 39, 449, 10.1016/S0197-0186(01)00052-3 · DOI
- Combs, 1999, Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins, J. Neurosci, 19, 928, 10.1523/JNEUROSCI.19-03-00928.1999 · DOI · Paper page
- Cras, 1990, Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease, Am. J. Pathol, 137, 241
- Das, 2006, 2-aminothiazole as a novel kinase inhibitor template, J. Med. Chem, 49, 6819, 10.1021/jm060727j · DOI · Paper page
- Del Bo, 1995, Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures, Neurosci. Lett, 188, 70, 10.1016/0304-3940(95)11384-9 · DOI · Paper page
- Frautschy, 1998, Microglial response to amyloid plaques in APPsw transgenic mice, Am. J. Pathol, 152, 307
- Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
- He, 2010, Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease, Nature, 467, 95, 10.1038/nature09325 · DOI · Paper page
- Johnson, 2005, Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells, Clin. Cancer Res, 11, 6924, 10.1158/1078-0432.CCR-05-0757 · DOI · Paper page
- Klegeris, 1997, Interaction of Alzheimer beta-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-alpha, Brain Res, 747, 114, 10.1016/S0006-8993(96)01229-2 · DOI
- Lombardo, 2004, Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays, J. Med. Chem, 47, 6658, 10.1021/jm049486a · DOI · Paper page
- Martin, 1994, Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex, Am. J. Pathol, 145, 1358
- Mattiace, 1990, Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors, Am. J. Pathol, 136, 1101
- McDonald, 1997, Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia, J. Neurosci, 17, 2284, 10.1523/JNEUROSCI.17-07-02284.1997 · DOI · Paper page
- McLean, 1999, Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease, Ann. Neurol, 46, 860, 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
- Morgan, 2005, Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics, J. Neuropathol. Exp. Neurol, 64, 743, 10.1097/01.jnen.0000178444.33972.e0 · DOI · Paper page
- Perlmutter, 1990, Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease, Neurosci. Lett, 119, 32, 10.1016/0304-3940(90)90748-X · DOI · Paper page
- Podlisny, 1995, Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture, J. Biol. Chem, 270, 9564, 10.1074/jbc.270.16.9564 · DOI · Paper page
- Roher, 1996, Morphology and toxicity of Abeta-(1–42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease, J. Biol. Chem, 271, 20631, 10.1074/jbc.271.34.20631 · DOI · Paper page
- Sasaki, 2002, Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites, Virchows Arch, 441, 358, 10.1007/s00428-002-0643-8 · DOI
- Shah, 2004, Overriding imatinib resistance with a novel ABL kinase inhibitor, Science, 305, 399, 10.1126/science.1099480 · DOI · Paper page
- Shankar, 2011, Isolation of low-n amyloid β-protein oligomers from cultured cells, CSF, and brain, Methods Mol. Biol, 670, 33, 10.1007/978-1-60761-744-0_3 · DOI · Paper page
- Trommsdorff, 1998, Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein, J. Biol. Chem, 273, 33556, 10.1074/jbc.273.50.33556 · DOI · Paper page
- Villemagne, 2010, Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease, J. Neurosci, 30, 6315, 10.1523/JNEUROSCI.5180-09.2010 · DOI · Paper page
- Wegiel, 2003, Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice, Acta Neuropathol, 105, 393, 10.1007/s00401-002-0660-3 · DOI
- Wood, 1991, Tyrosine phosphorylation systems in Alzheimer's disease pathology, Neurosci. Lett, 121, 12, 10.1016/0304-3940(91)90637-9 · DOI
Cited by
Hopperton, K. E., Mohammad, D., Trépanier, M. O., Giuliano, V, & Bazinet, R. P. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.246 · Cited by 622
Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
Decourt, B., Lahiri, D. K., & Sabbagh, M. N. (2017) · Current Alzheimer Research · doi:10.2174/1567205013666160930110551 · Cited by 371
Diabetes and Alzheimer’s disease crosstalk
Baglietto-Vargas, D., Shi, J., Yaeger, D. M., Ager, R., & LaFerla, F. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.005 · Cited by 256
Tau Oligomers and Fibrils Induce Activation of Microglial Cells
Morales, I., Jiménez, J. M., Mancilla, M., & Maccioni, R. B. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-131843 · Cited by 160
Acetate reduces microglia inflammatory signaling in vitro
Soliman, M. L., Puig, K. L., Combs, C. K., & Rosenberger, T. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07955.x · Cited by 131
“The BV2 microglia were obtained from Dr. Gary E. Landreth (Cleveland, OH, USA) and maintained until used as described previously (Dhawan et al. 2012).”
MethodSelf-citation
Metadata
- Authors
- Dhawan, G., Floden, A. M., & Combs, C. K.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 33
- Issue
- 10
- Pages
- 2247-2261
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2153710780
- Cited by
- 104
- References
- 29
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- NIH/NCRR (1P20 RR17699)
- NIH/NIA (1R01AG026330)
- NSF (EPS-0814442)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amyloid-β oligomers stimulate microglia through a tyrosine kinase dependent mechanism. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2011.10.027
- The paper
- Dhawan, G., Floden, A. M., & Combs, C. K. (2012). Amyloid-β oligomers stimulate microglia through a tyrosine kinase dependent mechanism. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2011.10.027
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.